Clinical Utility and Safety of Finerenone in Patients with Heart Failure: Rationale and Design of FINE Registry

This study will provide valuable real-world evidence on the clinical effectiveness and safety of finerenone across a wide range of HF patients, including those with reduced, mildly reduced, and preserved ejection fraction. By leveraging a large, representative, and controlled cohort, the findings aim to enhance clinical decision-making and optimize the use of finerenone in routine practice, particularly in high-risk patients with complex co-morbidities.

Authors

Institutions

Publication Details

Journal
ESC Heart Failure
Published
2025-02-28
DOI
https://doi.org/10.1002/ehf2.15260
Citations
2
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
2.78

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Utility and Safety of Finerenone in Patients with Heart Failure: Rationale and Design of FINE Registry

Vanessa Escolar, Ana Huerta, Luis Gutiérrez de la Varga, Alejandro Recio‐Mayoral et al.
2 citations
ESC Heart Failure
Heart Failure Treatment and Management
2.78
article

Clinical Utility and Safety of Finerenone in Patients with Heart Failure: Rationale and Design of FINE Registry

Vanessa Escolar, Ana Huerta, Luis Gutiérrez de la Varga, Alejandro Recio‐Mayoral, Jesús Piqueras‐Flores, David González Calle, Rafael González Manzanares, Aleix Fort, Marta Cobo Marcos, Francisco J. Pastor‐Pérez, Pablo Díez‐Villanueva, Juan Górriz‐Magaña, José María Viéitez Flórez, Gonzalo Luis Alonso Salinas, Juan Quiles, Alberto Esteban‐Fernández, Inés Ponz, Cristina Salazar Mosteiro, David A. Cano, Amaia Martínez León, Pedro Caravaca Pérez, María Ferré Vallverdú, Pau Codina, Inés Gómez‐Otero, Eddy Lincango, Gisselle Gallego, Clara Bonanad, Néstor Báez‐Ferrer, María Jesús Pinilla Lozano, Simón Díaz, Luís Almenar, Gregorio Delgado, Sandra Valdivieso‐Moré
article en
2 citations

Abstract

This study will provide valuable real-world evidence on the clinical effectiveness and safety of finerenone across a wide range of HF patients, including those with reduced, mildly reduced, and preserved ejection fraction. By leveraging a large, representative, and controlled cohort, the findings aim to enhance clinical decision-making and optimize the use of finerenone in routine practice, particularly in high-risk patients with complex co-morbidities.

ESC Heart FailureVol. 12(4)
Universidad Pública de Navarra (UPNA) (ES), Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital Universitario Virgen Macarena (ES), Hospital de Basurto (ES), Hospital General Nuestra Señora del Prado (ES), Hospital Clínico Universitario de Valencia (ES), Complejo Hospitalario Universitario de Santiago (ES), Complejo Hospitalario de Navarra (ES), Hospital Universitario de Gran Canaria Doctor Negrín (ES), Complejo Hospitalario de Salamanca (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Navarre Institute of Health Research (ES), Hospital Clínic de Barcelona (ES), Hospital General Universitario de Ciudad Real (ES), Navarrabiomed (ES), Hospital Universitario Reina Sofía (ES), Hospital Universitario de La Princesa (ES), Hospital Del Mar (ES), Hospital Universitario Central de Asturias (ES), Clinica Universidad de Navarra (ES), Hospital Clínico Universitario Lozano Blesa (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Hospital Universitario Lucus Augusti (ES), Hospital Quirón Torrevieja (ES), Hospital Universitari Sant Joan de Reus (ES), Hospital Universitario Virgen de la Arrixaca (ES), Hospital Universitari Germans Trias i Pujol (ES), Hospital Universitari de Girona Doctor Josep Trueta (ES), Complejo Hospitalario Universitario de Albacete (ES), Hospital Universitario Severo Ochoa (ES), Hospital Universitario Ramón y Cajal (ES), Hospital Central de la Defensa Gómez Ulla (ES), Universidad de Navarra (ES)
Sociedad Española de Cardiología, European Society of Cardiology
Openalex Percentile: Top 11%
Heart Failure Treatment and Management
2.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.